Search Results - "Lesprit, P."

Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams by Weiss, E., Zahar, J.-R., Lesprit, P., Ruppe, E., Leone, M., Chastre, J., Lucet, J.-C., Paugam-Burtz, C., Brun-Buisson, C., Timsit, J.-F., Brun-Buisson, C., Bruneel, F., Chastre, J., Lasocki, S., Leone, M., Montravers, P., Nseir, S., Paugam-Burtz, C., Pease, S., Timsit, J.-F., Weiss, E., Wolff, M., Alfandari, S., Fantin, B., Gachot, B., Lesprit, P., Lucet, J.-C., Potel, G., Pulcini, C., Rabaud, C., Tattevin, P., Armand-Lefevre, L., Cavallo, J.-D., Jarlier, V., Joint-Lambert, O., Robert, J., Ruppé, E., Woerther, P.-L.

“…Empirical broad spectrum antimicrobial therapy prescribed in life-threatening situations should be de-escalated to mitigate the risk of resistance emergence…”
Get full text

Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase–producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis by Senard, O., Lafaurie, M., Lesprit, P., Nguyen, Y., Lescure, X., Therby, A., Fihman, V., Oubaya, N., Lepeule, R.

“…Cefoxitin has demonstrated good in vitro activity against extended spectrum beta-lactamase (ESBL)–producing Escherichia coli (ESBL-Ec) and is regarded as a…”
Get full text

Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial by Lesprit, P., Landelle, C., Brun-Buisson, C.

“…This study aimed to determine the clinical course of patients and the quality of antibiotic use using a systematic and unsolicited postprescription antibiotic…”
Get full text

Terms of use of outpatient parenteral antibiotic therapy by Diamantis, S., Longuet, P., Lesprit, P., Gauzit, R.

Get full text

Home intravenous antibiotherapy and the proper use of elastomeric pumps: Systematic review of the literature and proposals for improved use by Diamantis, S., Dawudi, Y., Cassard, B., Longuet, P., Lesprit, P., Gauzit, R.

“…Over several decades, the economic situation and consideration of patient quality of life have been responsible for increased outpatient treatment. It is in…”
Get full text

Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign by Vallée, A., Chan-Hew-Wai, A., Bonan, B., Lesprit, P., Parquin, F., Catherinot, É., Choucair, J., Billard, D., Amiel-Taieb, C., Camps, È., Cerf, C., Zucman, D., Fourn, E.

“…A strong COVID-19 vaccine campaign is needed to reach the herd immunity and reduce this pandemic infection. In the Foch Hospital, France, in February 2021, 451…”
Get full text

COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis by Farfour, E., Ballester, M-C., Lecuru, M., Verrat, A., Imhaus, E., Mellot, F., Karnycheff, F., Vasse, M., Cerf, C., Lesprit, P.

Get full text

Erratum to “Diamantis S, Longuet P, Lesprit P, Gauzit R. Terms of use of outpatient parenteral antibiotic therapy” Med Mal Infect. 2020 Jun 20:S0399-077X(20)30153-0. doi: 10.1016/j.medmal.2020.06.004. [Online ahead of print.] by Diamantis, S., Longuet, P., Lesprit, P., Gauzit, R.

Get full text

Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) - 2023 SPILF by Bonnet, E, Maulin, L, Senneville, E, Castan, B, Fourcade, C, Loubet, P, Poitrenaud, D, Schuldiner, S, Sotto, A, Lavigne, J P, Lesprit, P

“…In march 2020, the International Working Group on the Diabetic Foot (IWGDF) published an update of the 2015 guidelines on the diagnosis and management of…”
Get full text

Reply to comments on “Impact of EUCAST rapid Antimicrobial Susceptibility testing (RAST) on management of Gram-negative bloodstream infection” by Cardot-Martin, E., Colombier, M.A., Limousin, L., Farfour, E., Lesprit, P., Vasse, M.

Get full text

Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice? by Pilmis, B, Delory, T, Groh, M, Weiss, E, Emirian, A, Lecuyer, H, Lesprit, P, Zahar, J.-R

“…Highlights • De-escalation after empirical treatment with a carbapenem is rarely done. • Escherichia coli -related infection was found to be a protective…”
Get full text

Postprescription review improves in-hospital antibiotic use: A multicenter randomized controlled trial by Lesprit, P., de Pontfarcy, A., Esposito-Farese, M., Ferrand, H., Mainardi, J.L., Lafaurie, M., Parize, P., Rioux, C., Tubach, F., Lucet, J.C.

“…Although review of antibiotic therapy is recommended to optimize antibiotic use, physicians do not always perform it. This trial aimed to evaluate the impact…”
Get full text

Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations by Gauzit, R., Castan, B., Bonnet, E., Bru, J.P., Cohen, R., Diamantis, S., Faye, A., Hitoto, H., Issa, N., Lebeaux, D., Lesprit, P., Maulin, L., Poitrenaud, D., Raymond, J., Strady, C., Varon, E., Verdon, R., Vuotto, F., Welker, Y., Stahl, J.P.

Get full text

Unsolicited post-prescription antibiotic review in surgical and medical wards: factors associated with counselling and physicians’ compliance by Lesprit, P., Landelle, C., Brun-Buisson, C.

“…The purpose of this investigation was to describe the impact of an early review of antibiotic prescriptions in a hospital using unsolicited infectious disease…”
Get full text

New Bacteriological Patterns in Primary Infected Aorto-iliac Aneurysms: A Single-centre Experience by Brossier, J, Lesprit, P, Marzelle, J, Allaire, E, Becquemin, J.-P, Desgranges, P

“…Abstract Objectives To assess causative pathogens and surgical outcomes in patients with primary infected aorto-iliac aneurysms at our institution. Design…”
Get full text

Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis by Delory, T., De Pontfarcy, A., Emirian, A., About, F., Berdougo, B., Brun-Buisson, C., Lesprit, P.

“…The objective of this study was to assess the impact on carbapenems use of a program combining pre-authorization requirement and systematic post-prescription…”
Get full text

Campylobacter fetus bloodstream infection: risk factors and clinical features by Gazaigne, L., Legrand, P., Renaud, B., Bourra, B., Taillandier, E., Brun-Buisson, C., Lesprit, P.

“…In this paper, we report 21 cases of Campylobacter fetus bloodstream infection observed in our institution over a 9-year period. The median age of the patients…”
Get full text

Survey on infectious disease telephone hotlines in primary care: General practitioners’ satisfaction and compliance with advice by Sette, A.-L., Pavese, P., Lesprit, P., Maillet, M., Bourgeois, G., Lutz, M.-F., Baldeyrou, M., Mondain, V., Suy, F., Contejean, A., Diamantis, S., Poitrenaud, D., Touati, S., Boussat, B., François, P.

“…•Infectious disease (ID) advice is a main component of antimicrobial stewardship programs.•Improving the use of antibiotics in general practice is of global…”
Get full text

Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures by Cattoir, V., Merabet, L., Djibo, N., Rioux, C., Legrand, P., Girou, E., Lesprit, P.

“…The full identification and susceptibility profile of staphylococci from positive blood cultures (BCs) generally takes 24–48 h using phenotypic methods. The…”
Get full text

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America by Girardi, Enrico, Sabin, Caroline A, d'Arminio Monforte, Antonella, Hogg, Bob, Phillips, Andrew N, Gill, M John, Dabis, Francois, Reiss, Peter, Kirk, Ole, Bernasconi, Enos, Grabar, Sophie, Justice, Amy, Staszewski, Schlomo, Fätkenheuer, Gerd, Sterne, Jonathan A C

“…Background. We obtained estimates of the incidence of tuberculosis (TB) among patients receiving HAART and identified determinants of the incidence. Methods…”
Get full text